CD19 and plasma cell myeloma: Recent studies confirm that CD19 is expressed at an ultra-low density on a fraction of myeloma cells (10.3–80%) in the majority of patients, and CD19low myeloma cells can be eliminated by anti-CD19 CAR T cells18.